PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization... Show more
PAVM is expected to report earnings to rise 6,500.00% to -66 cents per share on November 12
Q3'26
Est.
$-0.66
Q4'24
Beat
by $1.64
Q4'23
Beat
by $0.51
Q3'23
Beat
by $0.05
Q2'23
Missed
by $0.05
The last earnings report on March 24 showed earnings per share of 0 cents, beating the estimate of -164 cents. With 4.75K shares outstanding, the current market capitalization sits at 17.19M.